Literature DB >> 10644557

Motilin receptors in the human antrum.

P Miller1, A Roy, S St-Pierre, M Dagenais, R Lapointe, P Poitras.   

Abstract

Motilin is an intestinal peptide that stimulates contraction of gut smooth muscle. The motilin receptor has not been cloned yet, but motilin-receptor agonists appear to be potent prokinetic agents for the treatment of dysmotility disorders. The aim of this study was to determine neural or muscular localization of motilin receptors in human upper gastrointestinal tract and to investigate their pharmacological characteristics. The binding of (125)I-labeled motilin to tissue membranes prepared from human stomach and duodenum was studied; rabbit tissues were used for comparison. Solutions enriched in neural synaptosomes or in smooth muscle plasma membranes were obtained. Various motilin analogs were used to displace the motilin radioligand from the various tissue membranes. The highest concentration of human motilin receptors was found in the antrum, predominantly in the neural preparation. Human motilin receptors were sensitive to the NH(2)-terminal portion of the motilin molecule, but comparison with rabbit showed that both species had specific affinities for various motilin analogs [i.e., Mot-(1-9), Mot-(1-12), Mot-(1-12) (CH(2)NH)(10-11), and erythromycin]. Motilin receptors obtained from synaptosomes or muscular plasma membranes of human antrum expressed different affinity for two motilin-receptor agonists, Mot-(1-12) and Mot-(1-12) (CH(2)NH)(10-11), suggesting that they correspond to specific receptor subtypes. We conclude that human motilin receptors are located predominantly in nerves of the antral wall, are functionally (and probably structurally) different from those found in other species such as the rabbit, and express specific functional (and probably structural) characteristics dependent on their localization on antral nerves or muscles, suggesting the existence of specific receptor subtypes, potentially of significant physiological or pharmacological relevance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644557     DOI: 10.1152/ajpgi.2000.278.1.G18

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  14 in total

1.  Can small non-peptide motilin agonists force a breakthrough as gastroprokinetic drugs?

Authors:  Inge Depoortere
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?

Authors:  Manfred Hauben; Guy W Amsden
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Effects of motilin and mitemcinal (GM-611) on gastrointestinal contractile activity in rhesus monkeys in vivo and in vitro.

Authors:  Kenji Yogo; Ken-Ichi Ozaki; Hisanori Takanashi; Masao Koto; Zen Itoh; Satoshi Omura
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

4.  The rabbit motilin receptor: molecular characterisation and pharmacology.

Authors:  N B Dass; J Hill; A Muir; T Testa; A Wise; G J Sanger
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

5.  Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function.

Authors:  Ingrid M C Kamerling; Aernout D van Haarst; Jacobus Burggraaf; Rik C Schoemaker; Marieke L de Kam; Hartmut Heinzerling; Adam F Cohen; Ad A M Masclee
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

6.  Effect of Aspiration and Evaluation of Gastric Residuals on Intestinal Inflammation, Bleeding, and Gastrointestinal Peptide Level.

Authors:  Leslie A Parker; Michael Weaver; Roberto J Murgas Torrazza; Jonathon Shuster; Nan Li; Charlene Krueger; Josef Neu
Journal:  J Pediatr       Date:  2019-11-19       Impact factor: 4.406

7.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.

Authors:  John Broad; Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.

Authors:  J Broad; S Mukherjee; M Samadi; J E Martin; G E Dukes; G J Sanger
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

9.  Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.

Authors:  Marie Lund; Björn Pasternak; Rie B Davidsen; Bjarke Feenstra; Camilla Krogh; Lars J Diaz; Jan Wohlfahrt; Mads Melbye
Journal:  BMJ       Date:  2014-03-11

10.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.